Request TOC and Sample - Infectious Disease Biomarker Testing Market by Biomarker Type (Circulating Biomarkers, Surrogate Biomarkers, Endogenous Biomarkers, Other Biomarkers), by Technology (ELISA, Multiplex Assays, PCR, Mass Spectrometry, Flow Cytometry, Sequencing, Nucleic Acid System), by Application (Diagnosis, Drug Response Monitoring, Risk Assessment/Prognosis, Surveillance, Analytical Assay Validation) and by End-User (Hospitals and Clinics, Academic and Research Institutes, Diagnostic Centers, Other End-Users): Opportunity Analysis and Industry Forecast, 2023-2032

Infectious Disease Biomarker Testing Market, by Biomarker Type (Circulating Biomarkers, Surrogate Biomarkers, Endogenous Biomarkers, Other Biomarkers), by Technology (ELISA, Multiplex Assays, PCR, Mass Spectrometry, Flow Cytometry, Sequencing, Nucleic Acid System), by Application (Diagnosis, Drug Response Monitoring, Risk Assessment/Prognosis, Surveillance, Analytical Assay Validation) and, by End-User (Hospitals and Clinics, Academic and Research Institutes, Diagnostic Centers, Other End-Users): Opportunity Analysis and Industry Forecast, 2023-2032